Bank Of New York Mellon Corp Harvard Bioscience Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.45 - $4.22 $329,645 - $567,796	134,549 New	134,549 $565 Million
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $285,243 - $384,810	134,549 New	134,549 $372,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $11,011 - $18,525	-4,726 Reduced 2.81%	163,300 $419,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $322,384 - $631,008	-98,288 Reduced 36.91%	168,026 $605,000
Q1 2022 May 11, 2022	BUY	$5.16 - $7.14 $93,752 - $129,726	18,169 Added 7.32%	266,314 $1.65 Million
Q4 2021 Feb 11, 2022	BUY	$6.37 - $8.18 $183,596 - $235,763	28,822 Added 13.14%	248,145 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $111,463 - $135,257	15,969 Added 7.85%	219,323 $1.53 Million
Q2 2021 Aug 11, 2021	BUY	$5.44 - $8.4 $248,031 - $382,989	45,594 Added 28.9%	203,354 $0
Q1 2021 May 13, 2021	BUY	$3.91 - $6.99 $182,937 - $327,041	46,787 Added 42.16%	157,760 $0
Q4 2020 Feb 09, 2021	SELL	$3.0 - $4.5 $7,224 - $10,836	-2,408 Reduced 2.12%	110,973 $0
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $4,001 - $6,111	1,455 Added 1.3%	113,381 $0
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.14 $207,548 - $307,406	97,900 Added 697.99%	111,926 $0
Q2 2019 Aug 12, 2019	SELL	$1.93 - $4.59 $185,031 - $440,047	-95,871 Reduced 87.24%	14,026 $28,000
Q1 2019 May 14, 2019	SELL	$2.77 - $4.38 $2,116 - $3,346	-764 Reduced 0.69%	109,897 $473,000
Q4 2018 Feb 11, 2019	BUY	$3.03 - $5.0 $24,279 - $40,065	8,013 Added 7.81%	110,661 $352,000
Q3 2018 Nov 09, 2018	SELL	$5.0 - $6.65 $80,685 - $107,311	-16,137 Reduced 13.59%	102,648 $0
Q2 2018 Aug 06, 2018	BUY	$4.2 - $5.95 $321,783 - $455,859	76,615 Added 181.68%	118,785 $636,000
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $19,090 - $29,792	5,785 Added 15.9%	42,170 $211,000
Q4 2017 Feb 09, 2018	BUY	$3.08 - $3.8 $112,065 - $138,263	36,385	36,385 $120,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

Black Rock Inc. New York, NY

2.84M
Shares

$6.17 Million
0.0% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.77M
Shares

$6.02 Million
0.44% of portfolio
Harvey Partners, LLC Tarrytown, NY

2.72M
Shares

$5.89 Million
0.87% of portfolio
Amh Equity LTD

2.39M
Shares

$5.18 Million
8.88% of portfolio
Vanguard Group Inc Valley Forge, PA

2.15M
Shares

$4.67 Million
0.0% of portfolio

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account